- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01018108
Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors
Effect of Acupuncture on Brain Serotonin Among Breast Cancer Survivors
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Detailed Description
OBJECTIVES:
I. To determine the feasibility of using [123-I] ADAM Serotonin transporter (SERT) binding as a putative biomarker to visualize the mechanism of effects of acupuncture for hot flashes involving serotonin.
OUTLINE: Patients undergo acupuncture twice weekly for 2 weeks and then once weekly for 6 weeks. Patients undergo single photon emission computed tomography imaging with iodine 123-I ADAM before and after completion of acupuncture.
After completion of study treatment, patients are followed for 4 weeks.
Studietype
Inschrijving (Verwacht)
Fase
- Fase 1
Contacten en locaties
Studie Locaties
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104
- Abramson Cancer Center of the University of Pennsylvania
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- History of Stage I, II, or III breast cancer for at least 12 months
- Have been seen by an oncologist within the previous 6-month period and determined to be free of disease by clinical examination and history
- Have been receiving endocrine therapy (tamoxifen or aromatase inhibitors for at least four weeks)
- Experienced hot flashes with a hot flash composite score of 5 or greater per day
- Hot flashes have been present for at least a month before study entry
Exclusion Criteria:
- Currently on chemotherapy or radiation therapy as adjuvant treatment
- Started with hormonal therapies such as tamoxifen or aromatase inhibitors within the last 4 weeks; or plan to change or terminate hormonal therapies in the next 14 weeks
- Any history of use of psychotropic medication such as SSRI use for the past 6 months
- Any past use of centrally acting medications such as clonidine for the past 6 months
- Any past diagnosis of a Major Depressive Episode within the last 6 months
- Any allergy to iodine or shell-fish or radio-nuclear materials
- Current use of estrogen and/or progestin
- Pregnancy
- Breast feeding
- Women of child-bearing potential NOT willing to use a medically acceptable form of contraception
- Current use of any anti-convulsant such as gabapentin
- History of cerebral infarction (including lacunar infarct with symptoms >= 24 hours duration)
- History of Binswanger's disease (or a history of hypertensive encephalopathy)
- History of intracranial hemorrhage
- History of head trauma with loss of consciousness
- History of encephalitis
- History of extended exposure to known neurotoxin (e.g., cyanide, carbon monoxide)
- Uncontrolled metabolic disorder (e.g., thyroid disease, diabetes mellitus)
- History of normal pressure hydrocephalus
- History of Parkinson's or other basal ganglia disease
- History of substance abuse in the previous 6 months
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Diagnostisch
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Ander: I
Patients undergo acupuncture twice weekly for 2 weeks and then once weekly for 6 weeks.
Patients undergo single photon emission computed tomography imaging with iodine 123-I ADAM before and after completion of acupuncture.
|
Undergo single photon emission computed tomographt imaging
Andere namen:
Onderga acupunctuur
Andere namen:
Aanvullende studie
Correlative Study
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
|---|
|
SERT uptake ratios
|
|
Hot flash composite score (HFCS)
|
Secundaire uitkomstmaten
Uitkomstmaat |
|---|
|
Hot flash related daily interference scale (HFRDIS)
|
|
Pittsburgh sleep quality index (PSQI)
|
|
Brief Fatigue Inventory (BFI)
|
|
HADS
|
|
Global assessment scale
|
|
Frequentie en ernst van opvliegers
|
|
Acupuncture expectancy scale
|
|
Credibility rating of acupuncture
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- UPCC 17108
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .